About Us

HONG KONG AMORGEVITY R&D CENTER

A Hong Kong-based precision longevity institution dedicated to reversing biological age through data-driven science.

Born from Scientific Conviction

Our Story

Born from Scientific Conviction

AMORGEVITY — a fusion of love (Amor) and longevity — was founded with the conviction that extending human healthspan deserves the same rigor as any great medical institution.

Led by Dr. Vince Gao, our Hong Kong R&D Center bridges Eastern wellness wisdom and Western biomedical innovation, developing patented BPO® and GMDAI® technologies for precision healthy longevity.

Differentiation

What Makes Us Different

BPO Biological Pathway Omics
01

BPO® Biological Pathway Omics

Patented platform integrating genotypic, phenotypic, AI, and intervention product platforms (US Patent 11,610,643 B2).

AI Closed-Loop Monitoring
02

AI Closed-Loop Monitoring

Personalized assessment, formulation, and longitudinal biological age tracking with 220+ lifestyle and geroprotector combinations.

International Standards
03

International Standards

GMP manufacturing, ISO-certified laboratories, 2021 CDC global quality control champion.

Global Collaborations
04

Global Collaborations

Partnerships with KAO Institute, CHIVITR Thailand, HKU AI-health, and leading longevity institutions worldwide.

Leadership

Core Team

Dr. Vince Gao

Co-Founder, CSO & CTO

Dr. Vince Gao, serves as Chief Executive Officer and Chief Scientific Officer, has more than 18 years' experience in leading life science R&D and business. Dr. Gao has a deep passion for using high-technology to improve people's health and quality of life and increase the value of medical services. Most recently he served as the Executive President of Health Division of BGI, the world largest genomics company, where he pioneered the MS-Seq test for inborn errors of metabolism won the Top 10 Innovative Product Award at the 2013 China International Innovation Expo and his multi-omics preventive health approach served thousands of clients. Prior to joining BGI, Dr. Gao spent over 14 years at a global leading life science company AB Sciex for a variety of executive roles, including Laboratory Director for Japan and China, China General Manager and Asia Pacific Senior Business Director driving over USD $100 million annual business and overseeing more than 100 staff. Prior to joining AB Sciex, Dr. Gao served as the Senior Scientist of Drug Metabolism at AstraZeneca, a world-class pharmaceutical company, where he contributed significantly the development of an anti-breast cancer drug Arimidex of over USD $1 billion annual revenue. Prior to joining AstraZeneca, Dr. Gao served as Scientist at Hemagen, an US regenerative medicine company. Dr. Gao received his MS and PhD degrees in Bioanalytical Chemistry from The Northeastern University in the US.

Dr. Lulu Liu

Operations Director

Dr. Lulu Liu serves as Operations Director and has more than 10 years of experience in bioanalytical R&D and more than 3 years of experience in managing commercial laboratory. Dr. Liu has a great passion for using LCMSMS platform to develop novel methods in different applied market. Most recently she served as the Deputy Department Manager of SGS (SZ), the world leading 3rd-party testing company, where she oversaw central lab QA and daily operation to assure high quality report provided to clients on time. Prior to joining SGS, Dr. Liu studied and worked in UCLA Olympic Analytical Laboratory, focusing on developing alternative and novel method to detect testosterone doping. Dr. Liu received her PhD degree in Peking Union Medical College, Beijing.

Dr. Wings Loo

Sr. Medical Lab Technologist

Dr. Wings Loo is our Senior Medical Laboratory Technologist. He has more than 15 years of experience in the field of genetic, epigenetic and biological markers. He completed his PhD projects in endocrine biomarkers in Tohoku University School of Medicine, Japan. Dr Loo has obtained another PhD at the Faculty of Dentistry, The University of Hong Kong investigating genetic aberrations in oral disease subjects. He has completed his post-doctoral fellow's project in the West China College of Stomatology, Sichuan University studying the correlation of genes of cytokines, inflammatory mediators and alveolar bone resorption in control and periodontitis patients. Recently, Dr. Loo has applied Tai Chi Chuan as a tool to relieve stress and aging in cancer survivors and healthy subjects, their biomarkers were compared. He is currently participating research projects in West China College of Stomatology, Sichuan University and Xiangya Hospital, Central South University. These include application of stem cells for anti-aging, and the correlation of genetic factors and bone resorption.

Dr. Wu Qian

Lab Manager

Dr. Wu received her Ph.D. from City University of Hong Kong and has 15 years of experience in LC-MS analysis. Her research interests include cutting-edge LC-MS technologies and their applications in drug, environmental, and biomedical analysis. She focuses on LC-MS/MS-based clinical metabolic analysis, advancing mass spectrometry in functional and preventive medicine to improve people's health and quality of life.

Dr. Janice Wong

Product R&D Manager

Dr. Janice Wong earned her bachelor's, master's, and doctoral degrees from the Chinese University of Hong Kong. Her research spans protein markers of asthma; genetic mutations, gene functions, and biomarkers in stem cells from patients with endocrine and autoimmune diseases; and genetic studies of endocrine disorders. After completing her master's and doctorate, she applied her expertise in cellular, molecular, and genetic science to lead genetics teams advancing preventive medicine.

Mr. Hans Huang

AI & IT Manager

Mr. Hans Huang received his bachelor's degree in chemical technology from the Hong Kong Polytechnic University and his master's degree in nutrition science from the Chinese University of Hong Kong. With his background in life science and programming, he focuses on applying advanced biological knowledge to products and services as Bioinformatics / IT Manager.

Luo Mingke

Chief Financial Officer

Luo Mingke oversees finance and legal affairs at AMORGEVITY, bringing expertise in financial reporting, audit, and investment management. He holds an M.Sc. from the Hong Kong University of Science and Technology and supports the organization's growth with disciplined financial governance and strategic investment oversight.

Advisors

Scientific Advisory Board

Prof. Al Chalabi

Functional & Longevity Medicine

30+ years longevity consulting; CityU adjunct professor; author of "Investing in the Longevity Era"

Dr. Miles Price

Functional Medicine Physician

IFMCP certified; 16 years clinical practice in metabolic health and longevity

Dr. Moshe Szyf

Biotechnology Advisor

International pioneer in epigenetics and DNA methylation cancer screening

Prof. Yung Hou Wong

Biotechnology Advisor

HKUST Dean of Science; molecular neuroscience and aging science research leader

Dr. Ryan Smith

Medical Technology Advisor

Founder & R&D President, TruDiagnostic; epigenetic biological age testing pioneer

Dr. Richard Walker

Biotechnology Advisor

International expert in aging theory research and intervention practice

Dr. Singh Ravinder

Medical Technology Advisor

Mayo Clinic Endocrine Laboratory Director; clinical mass spectrometry expert

Dr. Chia Chi Kao

Longevity Medicine Advisor

Founder, KAO Anti-Aging Institute; Hollywood regenerative medicine pioneer

Collaborations

Our Partners

KAO Longevity Institute
CHIVITR
Hong Kong University of Science and Technology
IMI
LifeClinic
Optimal
OT&P
Restore Integrative Medical Clinic

Partner With Us

We welcome collaborations with research institutions, medical professionals, and discerning partners.

Get in Touch